Catalent Japan K.K. |
Name | Catalent Japan K.K. | ![]() |
|
---|---|---|---|
Address | 4-9-17 Akasaka, Minato-ku, Tokyo 107-0052 JAPAN |
||
Phone | +81-3-3470-2311 | ||
FAX | +81-3-3408-5554 | ||
URL | http://www.catalent.co.jp/ | ||
Contact | Hironori Kubota, Pharma Sales | ||
Our Strength |
A Japanese subsidiary of Catalent Pharma Solutions Company, headquartered in New Jersey, U.S.A., provides unique products and services throughout Japan and worldwide. Catalent Japan has Kakegawa plant in Kakegawa City, Shizuoka prefecture and has been engaged in contract manufacturing of soft capsules for pharmaceutical and health food products since 1970. In particular, plant-derived soft capsule Vegicaps® have earned wide reputations inside and outside of Japan since its first launch in 2007. In addition, the laboratory of Zydis®, an orally disintegrating tablet, was established for a preliminary formulation study in the plant since October 2014.
The Catalent group owns innovative drug delivery system technologies such as improving the absorption of poorly water-soluble compounds. The group owns 11 soft capsule manufacturing plants worldwide, in Japan, the US (2), Brazil (2), Argentina, Germany, France, Italy, China and Australia, and each plant complies with respective regulations by each regions. various services are globally available such as orally disintegrating tablet technology Zydis® (UK, US and Japan), sustained release tablet and hot melt extrusion technology (US, Germany), sterile products such as injection/BFS products (US, Belgium and France), inhalants (US), biologics GPEx® (US), investigational product manufacturing/packaging/storage/delivery (US, Germany, UK, Singapore, China and others), salt/polymorphism screening technology (US), and development services (US).
For those pharmaceutical companies that need to overcome any formulation difficulties and are considering those market globally, Catalent is the best solution provider.